|
Volumn 57, Issue 3, 2006, Pages 343-348
|
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2' FLUORODEOXYURACIL ARABINOFURANOSIDE;
2'-FLUORODEOXYURACIL-ARABINOFURANOSIDE;
CONTRAST MEDIUM;
DIAGNOSTIC AGENT;
DRUG DERIVATIVE;
FLUORODEOXYGLUCOSE F 18;
URACIL ARABINOSIDE;
ARTICLE;
BONE MARROW;
BREAST TUMOR;
CLINICAL TRIAL;
COLORECTAL TUMOR;
COMPARATIVE STUDY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY;
LIVER TUMOR;
LUNG TUMOR;
LYMPH NODE METASTASIS;
METABOLISM;
METASTASIS;
METHODOLOGY;
PATHOLOGY;
PILOT STUDY;
POSITRON EMISSION TOMOGRAPHY;
SCINTISCANNING;
TIME;
TISSUE DISTRIBUTION;
ARABINOFURANOSYLURACIL;
BONE MARROW;
BREAST NEOPLASMS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
COLORECTAL NEOPLASMS;
CONTRAST MEDIA;
FLUORODEOXYGLUCOSE F18;
HUMANS;
INJECTIONS, INTRAVENOUS;
KIDNEY;
LIVER NEOPLASMS;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
PILOT PROJECTS;
POSITRON-EMISSION TOMOGRAPHY;
TIME FACTORS;
TISSUE DISTRIBUTION;
|
EID: 33644838157
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s00280-005-0037-0 Document Type: Article |
Times cited : (14)
|
References (0)
|